Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Commercial Spending Drives Q2 Volume Growth In U.S.

This article was originally published in The Tan Sheet

Executive Summary

Colgate second quarter volume sales grew 4.3% in North America and 5.2% in the U.S. excluding Simply White gel, demonstrating encouraging momentum driven by renewed focus and increases in commercial support behind core businesses, VP-Investor Relations Bina Thompson stated during an earnings call July 21

You may also be interested in...



Colgate Max Fresh

New whitening toothpaste scheduled to begin shipping Aug. 2 is infused with mini breath strips which "release an extra rush of breath freshening power," Colgate-Palmolive says. Colgate Max Fresh toothpaste is formulated in cool mint (peppermint) and clean mint (spearmint) flavors, both of which are available in a 6 oz tube and 4.6 oz liquid gel. The tube will be parity priced with Colgate Total, while the liquid gel will be priced in line with Colgate 2in1, the company says. A trial supporting the launch features two .75 oz tubes of each flavor in one pack, available in sidekick and power chute displays, Colgate says, noting it also will provide "heavy support" with TV and Internet ads, multiple FSIs, in-store displays, sampling and special packs...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097088

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel